Pitavastatina Bluepharma 2 mg Comprimido revestido por película

Pays: Portugal

Langue: portugais

Source: INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

Achète-le

Ingrédients actifs:

Pitavastatina

Disponible depuis:

Bluepharma Genéricos - Comércio de Medicamentos S.A.

Code ATC:

C10AA08

DCI (Dénomination commune internationale):

Pitavastatina

Dosage:

2 mg

forme pharmaceutique:

Comprimido revestido por película

Composition:

Pitavastatina cálcica 2.09 mg

Mode d'administration:

Via oral

Unités en paquet:

Blister 28 unidade(s)

classe:

3.7 - Antidislipidémicos

Type d'ordonnance:

MSRM

Groupe thérapeutique:

Genérico

Domaine thérapeutique:

pitavastatin

indications thérapeutiques:

Duração do Tratamento: Longa Duração

Descriptif du produit:

Número de Registo: 5789326 CNPEM: 50118331 CHNM: 10101550 Comercializado

Statut de autorisation:

Autorizado

Date de l'autorisation:

2020-01-30

Notice patient

                                $3529$'2(0

,1)$50('


)ROKHWRLQIRUPDWLYR,QIRUPD©¥RSDUDRXWLOL]DGRU

3LWDYDVWDWLQD%OXHSKDUPDPJPJHPJFRPSULPLGRVUHYHVWLGRVSRUSHO¯FXOD
3LWDYDVWDWLQD

/HLDFRPDWHQ©¥RWRGRHVWHIROKHWRDQWHVGHFRPH©DUDWRPDUHVWHPHGLFDPHQWRSRLV
FRQW«PLQIRUPD©¥RLPSRUWDQWHSDUDVL

&RQVHUYHHVWHIROKHWR3RGHWHUQHFHVVLGDGHGHROHUQRYDPHQWH7

&DVRDLQGDWHQKDG¼YLGDVIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR
(VWHPHGLFDPHQWRIRLUHFHLWDGRDSHQDVSDUDVL1¥RGHYHG£ORDRXWURV2
PHGLFDPHQWRSRGHVHUOKHVSUHMXGLFLDOPHVPRTXHDSUHVHQWHPRVPHVPRVVLQDLVGH
GRHQ©D

6HWLYHUTXDLVTXHUHIHLWRVLQGHVHM£YHLVLQFOXLQGRSRVV¯YHLVHIHLWRVLQGHVHM£YHLV
Q¥R7LQGLFDGRVQHVWHIROKHWRIDOHFRPRVHXP«GLFRRXIDUPDF¬XWLFR9HUVHF©¥R

2TXHFRQW«PHVWHIROKHWR
2TXH«3LWDYDVWDWLQD%OXHSKDUPDHSDUDTXH«XWLOL]DGR
2TXHSUHFLVDGHVDEHUDQWHVGHWRPDU3LWDYDVWDWLQD%OXHSKDUPD
&RPRWRPDU3LWDYDVWDWLQD%OXHSKDUPD
(IHLWRVLQGHVHM£YHLVSRVV¯YHLV
&RPRFRQVHUYDU3LWDYDVWDWLQD%OXHSKDUPD
$3529$'2(0

,1)$50('


&RQWH¼GRGDHPEDODJHPHRXWUDVLQIRUPD©·HV

2TXH«3LWDYDVWDWLQD%OXHSKDUPDHSDUDTXH«XWLOL]DGR

3LWDYDVWDWLQD%OXHSKDUPDFRQW«PXPDVXEVW¤QFLDFKDPDGDSLWDYDVWDWLQD(VWDSHUWHQFH
DXPJUXSRGHPHGLFDPHQWRVFKDPDGRVಯHVWDWLQDVರ3LWDYDVWDWLQD%OXHSKDUPD«
XWLOL]DGRSDUDFRUULJLURVQ¯YHLVGHJRUGXUDO¯SLGRVQRVHXVDQJXH8PGHVHTXLO¯EULRGDV
JRUGXUDVHVSHFLDOPHQWHGRFROHVWHUROSRGHSRUYH]HVSURYRFDUXPDWDTXHFDUG¯DFR
RXXPDFLGHQWHYDVFXODUFHUHEUDO

)RLOKHUHFHLWDGR3LWDYDVWDWLQD%OXHSKDUPDSRUTXHWHPXPGHVHTXLO¯EULRGDVJRUGXUDVH
DPXGDQ©DGHGLHWDHDOWHUD©·HVGRVHXHVWLORGHYLGDQ¥RIRUDPVXILFLHQWHVSDUDR
FRUULJLU'HYHFRQWLQXDUDID]HUDVXDGLHWDSDUDGLPLQXLURFROHVWHUROHDVDOWHUD©·HVGR
VHXHVWLORGHYLGDHQTXDQWRHVWLYHUDWRPDU3LWDYDVWDWLQD%OXHSKDUPD


2TXHSUHFLVDGHVDEHUDQWHVGHWRPDU3LWDYDVWDWLQD%OXHSKDUP
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                $3529$'2(0

,1)$50('


5(6802'$6&$5$&7(567,&$6'20(',&$0(172


120('20(',&$0(172

3LWDYDVWDWLQD%OXHSKDUPDPJFRPSULPLGRVUHYHVWLGRVSRUSHO¯FXOD
3LWDYDVWDWLQD%OXHSKDUPDPJFRPSULPLGRVUHYHVWLGRVSRUSHO¯FXOD
3LWDYDVWDWLQD%OXHSKDUPDPJFRPSULPLGRVUHYHVWLGRVSRUSHO¯FXOD


&20326,‰…248$/,7$7,9$(48$17,7$7,9$

3LWDYDVWDWLQD%OXHSKDUPDPJ
&DGDFRPSULPLGRFRQW«PPJGHSLWDYDVWDWLQDF£OFLFDHTXLYDOHQWHDPJGH
SLWDYDVWDWLQD

3LWDYDVWDWLQD%OXHSKDUPDPJ
&DGDFRPSULPLGRFRQW«PPJGHSLWDYDVWDWLQDF£OFLFDHTXLYDOHQWHDPJGH
SLWDYDVWDWLQD

$3529$'2(0

,1)$50('


3LWDYDVWDWLQD%OXHSKDUPDPJ
&DGDFRPSULPLGRFRQW«PPJGHSLWDYDVWDWLQDF£OFLFDHTXLYDOHQWHDPJGH
SLWDYDVWDWLQD

([FLSLHQWHVFRPHIHLWRFRQKHFLGR
&DGDFRPSULPLGRGHPJFRQW«PDSUR[LPDGDPHQWHPJGHODFWRVHPRQR
KLGUDWDGD

&DGDFRPSULPLGRGHPJFRQW«PDSUR[LPDGDPHQWHPJGHODFWRVHPRQR
KLGUDWDGD

&DGDFRPSULPLGRGHPJFRQW«PDSUR[LPDGDPHQWHPJGHODFWRVHPRQR
KLGUDWDGD

/LVWDFRPSOHWDGHH[FLSLHQWHVYHUVHF©¥R


)250$)$50$&Œ87,&$

&RPSULPLGRVUHYHVWLGRVSRUSHO¯FXOD

$3529$'2(0

,1)$50('


3LWDYDVWDWLQD%OXHSKDUPDPJ
&RPSULPLGRVUHYHVWLGRVSRUSHO¯FXODEUDQFRVRXTXDVHEUDQFRVUHGRQGRVELFRQYH[RV
FRPUDQKXUDQXPDGDVIDFHV$UDQKXUDGRFRPSULPLGRQ¥RVHGHVWLQD¢VXDGLYLV¥R

3LWDYDVWDWLQD%OXHSKDUPDPJ
&RPSULPLGRVUHYHVWLGRVSRUSHO¯FXODEUDQFRVRXTXDVHEUDQFRVUHGRQGRVELFRQYH[RV
Q¥RUDQKXUDGRV

3LWDYDVWDWLQD%OXHSKDUPDPJ
&RPSULPLGRVUHYHVWLGRVSRUSHO¯FXODEUDQFRVRXTXDVHEUDQFRVUHGRQGRVELFRQYH[RV
FRPUDQKXUDQXPDGDVIDFHV$UDQKXUDGRFRPSULPLGRQ¥RVHGHVWLQD¢VXDGLYLV¥R


,1)250$‰—(6&/1,&$6

,QGLFD©·HVWHUDS¬XWLFDV

3LWDYDVWDWLQD%OXHSKDUPD«LQGLFDGRQDUHGX©¥RGRVQ¯YHLVHOHYDGRVGHFROHVWHUROWRWDO
&7HGHFROHVWHURO/'//'/&HPDGXOWRVDGROHVFHQWHVHFULDQ©DVFRPL
                                
                                Lire le document complet